Clinical Trial

Beta Amyloid PET/CT in Various Aβ-Related Disease

Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the potential usefulness of 18F-92/AV45, 11C-PIB positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various Tau-related disease patients.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-12-05; most recent amendment 2025-06-03.
Trial Details
NCT Number NCT06725706
Lead Sponsor Tianjin Medical University
Collaborators: Tianjin Medical University General Hospital
Conditions Amyloid, Beta-Amyloid, Neurodegenerative Diseases
Enrollment 500 participants
Start Date 2012-09-01
Primary Completion 2027-12-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-04